Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

514 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer: Final Report of the OCUM Study.
Ruppert R, Junginger T, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, Sauer J, Lauscher J, Winde G, Thomasmeyer R, Stelzner S, Bambauer C, Scheunemann S, Faedrich A, Wollschlaeger D, Merkel S. Ruppert R, et al. Among authors: junginger t. J Clin Oncol. 2023 Aug 20;41(24):4025-4034. doi: 10.1200/JCO.22.02166. Epub 2023 Jun 19. J Clin Oncol. 2023. PMID: 37335957
MRI-Based Use of Neoadjuvant Chemoradiotherapy in Rectal Carcinoma: Surgical Quality and Histopathological Outcome of the OCUM Trial.
Kreis ME, Ruppert R, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, Sauer J, Winde G, Thomasmeyer R, Stelzner S, Bambauer C, Scheunemann S, Faedrich A, Junginger T, Hermanek P, Merkel S; OCUM group. Kreis ME, et al. Among authors: junginger t. Ann Surg Oncol. 2020 Feb;27(2):417-427. doi: 10.1245/s10434-019-07696-y. Epub 2019 Aug 14. Ann Surg Oncol. 2020. PMID: 31414295
Avoidance of Overtreatment of Rectal Cancer by Selective Chemoradiotherapy: Results of the Optimized Surgery and MRI-Based Multimodal Therapy Trial.
Ruppert R, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, Sauer J, Junginger T, Hermanek P, Merkel S; other members of the OCUM Group. Ruppert R, et al. Among authors: junginger t. J Am Coll Surg. 2020 Oct;231(4):413-425.e2. doi: 10.1016/j.jamcollsurg.2020.06.023. Epub 2020 Jul 19. J Am Coll Surg. 2020. PMID: 32697965
Selection of patients with rectal cancer for neoadjuvant therapy using pre-therapeutic MRI - Results from OCUM trial.
Stelzner S, Ruppert R, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, Sauer J, Lauscher J, Winde G, Thomasmeyer R, Bambauer C, Scheunemann S, Faedrich A, Wollschlaeger D, Junginger T, Merkel S. Stelzner S, et al. Among authors: junginger t. Eur J Radiol. 2022 Feb;147:110113. doi: 10.1016/j.ejrad.2021.110113. Epub 2021 Dec 28. Eur J Radiol. 2022. PMID: 35026621
Pretherapeutic MRI for decision-making regarding selective neoadjuvant radiochemotherapy for rectal carcinoma: interim analysis of a multicentric prospective observational study.
Ptok H, Ruppert R, Stassburg J, Maurer CA, Oberholzer K, Junginger T, Merkel S, Hermanek P. Ptok H, et al. Among authors: junginger t. J Magn Reson Imaging. 2013 May;37(5):1122-8. doi: 10.1002/jmri.23917. Epub 2013 Mar 22. J Magn Reson Imaging. 2013. PMID: 23526771 Clinical Trial.
514 results